Nov 09 2023
According to a recently published study, the use of oral CBD products is associated with a reduction in over-the-counter and prescription drug use and “significantly improves self-perception of general health”. The study was published in the journal Medical Cannabis and Cannabinoids and it was published online by the US National Library of Medicine. It was conducted …
Nov 03 2023
The findings of a study published yesterday “suggest that combinations of the tested doses of caffeine and CBD do not alter subjective drug effects”, and “no negative effects emerged”. The study is being published in the upcoming issue of the journal Experimental and Clinical Psychopharmacology, and it’s been published online ahead of print by the …
Nov 01 2023
According to a new study, access to CBD leads to a reduction in opioid use. “We investigate the impacts of state legalization of products containing cannabidiol (CBD), a non-psychoactive alternative to marijuana, on opioid prescribing rates”, states the abstract of the study, published in the Southern Economic Journal. “Research suggests that legalized medical marijuana may …
Oct 30 2023
Medical cannabis “is safe and highly effective for treating neuropathic pain and concomitant sleep disturbance”, states a new study. Titled Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases, the study was published in the peer-reviewed journal Medical Cannabis and Cannabinoids, and it was published …
Oct 28 2023
A new study published in the journal Pharmaceuticals found that “chronic CBG administration can provide at least 24 hours of antinociceptive effect” in an animal model of neuropathic pain. “Cannabigerol (CBG), derived from the cannabis plant, acts as an acute analgesic in a model of cisplatin-induced peripheral neuropathy (CIPN) in mice”, states the abstract of …
Oct 27 2023
According to a new study the marijuana compound cannabidiol (CBD) “decreased total seizures and seizure days compared to placebo when administered to dogs PO at 9 mg/kg/day.” Published in the Journal of Veterinary Internal Medicine, the study was conducted by researchers at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University. “Approximately 30% …
Oct 24 2023
A study published by the American Chemical Society has found “previously undiscovered cannabis compounds” that “yield a more complete understanding of the unique aromas that cannabis produces”. For the study, researchers “conducted coupled sensory and chemical analyses on 31 different ice hash rosin cannabis extracts to determine how different chemical classes affect the aroma of each.” …
Oct 19 2023
According to a new study medical cannabis reduces pain, opioid use and depression among those 65 and older. The study, published in the journal Biomedicines, is titled Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults. It was conducted by researchers at Soroka University Medical Center, Ben-Gurion University …
Oct 18 2023
According to a new study, “psilocybin therapy may be potentially acceptable and may feasibly help in supporting survivors of adverse childhood experiences with particularly strong benefits to those with more severe childhood adversity.” The study was conducted by researchers at the University of British Columbia, Simon Fraser University, Athabasca University, and University of Michigan, and …
Oct 16 2023
According to new research, eight weeks of using 50mg of CBD daily “may offer benefits in enhancing sleep quality in humans and improving immunosurveillance against cancer cells”. Conducted by researchers at the University of Northern Colorado, the University of Utah, the University of Illinois at Chicago and the University of Northern Colorado, the study is …
